Skip to main content
. 2024 Jul 10;10:37. doi: 10.1186/s40780-024-00361-x

Fig. 1.

Fig. 1

Clinical course of cases 1, 2, and 3. Dosages of ESV, NMV/RTV, and TAC, TAC trough levels, and renal function are shown. A Case 1, B Case 2, and C Case 3. ESV, ensitrelvir; NMV/RTV, nirmatrelvir/ritonavir; TAC, tacrolimus; eGFR, estimated glomerular filtration rate